摘要:
A compound of formula (I) or a salt thereof, or a solvate thereof, wherein: R2, R3 and R4 each independently represents hydrogen, alkyl, aryl or substituted aryl; R5 represents hydrogen, alkyl, aryl or substituted aryl; R6 and R7 each independently represents hydrogen, hydroxy, amino, alkoxy, optionally substituted aryloxy, optionally substituted benzyloxy, alkylamino, dialkylamino, halo, trifluoromethyl, trifluoromethoxy, nitro, alkyl, carboxy, carbalkoxy, carbamoyl, alkylcarbamoyl, or R6 and R7 together represent methylenedioxy, carbonyldioxy or carbonyldiamino; R8 represents hydrogen, hydroxy, alkanoyl, alkyl, aminoalkyl, hydroxyalkyl, carboxyalkyl, carbalkoxyalkyl, carbamoyl or aminosulphonyl; and Z1 and Z2 together with the carbon atom to which they are attached represent a heterocyclic group; a pharmaceutical composition comprising such a compound, a process for preparing such a compound and the use of such compound in medicine.
摘要:
hNBC3 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing hNBC3 polypeptides and polynucleotides in therapy, and diagnostic assays for such.
摘要:
NOVEL TREATMENT A novel treatment of arrhythmia in human or non-human mammals, comprising administering a compound having combined class III and class IV antiarrhythmic activity.
摘要:
Granulates comprising an effervescent couple of anhydrous powdered monosodium citrate and powdered sodium bicarbonate and prepared using a roller compactor are formulated into pharmaceutical compositions.
摘要:
Fused aryl derivatives are described as lusitropic agents for use in the treatment of cardiovascular disease where there is a component of diastolic failure.